Humans harboring missense mutations in the presenilin 1 (PS1) gene undergo progressive cerebral deposition of the 42-residue amyloid ␤-protein (A␤ 42 ) at an early age and develop severe Alzheimer's disease. A␤ 42 is selectively elevated in the conditioned media of cells expressing mutant but not wild-type PS1, indicating that presenilin mutations alter APP processing. Here we analyze the effects of various PS1 mutant constructs on the cellular production of A␤ 42 . A construct expressing only the PS1 N-terminal endoproteolytic fragment with the mutation Y115H causes no significant increase in A␤ 42 , whereas a full-length PS1 construct with the same mutation does. This result suggests that the pathogenic effect of mutant presenilins is produced by the full-length molecule even though only a minor proportion of total PS1 occurs as holoprotein in tissues and cell lines. We demonstrate that the effects of two different PS1 mutations are additive when engineered into the same PS1 molecule. Therefore, two mutations alter ␥-secretase processing of APP more than one and the PS1 mutations described to date do not cause the maximum possible PS1-mediated rise in A␤ 42 . When a PS1 mutation was expressed in cells carrying the APP V717I mutation, A␤ 42 rose dramatically to become the predominant secreted A␤ species, an observation of interest for transgenic modeling of AD. Our results are consistent with the hypothesis that presenilin is a major regulator of the proteolytic processing of APP by ␥-secretases.
INTRODUCTION
Alzheimer's disease (AD), a progressive neurodegenerative disorder, is associated with several risk factors, including inheritance. PS1 mutations are the most common known cause of familial early-onset AD (for review see Hardy, 1997) . The mechanism by which mutations in this gene cause the form of AD with the earliest age of onset is currently unknown. However, a series of studies during the past 2 years has provided strong evidence that mutant presenilins enhance the amyloidogenic processing of the ␤-amyloid precursor protein (APP) by selectively increasing the production of the most pathogenic form of A␤, A␤ (Younkin, 1995) . In all PS mutants analyzed to date, the ratio of A␤ 1-42 /A␤ 1-40 is consistently increased. This was first found in plasma and fibroblast conditioned media of PS1 and PS2 mutation carriers, indicating that the presenilin mutations have a systemwide effect (Scheuner et al., 1996) . Later, massive A␤ 42 deposition was demonstrated in the cortex and cerebellum of individuals with a PS1-linked mutation (Lemere et al., 1996) . Furthermore, a mutated PS1 gene was shown to be sufficient to cause increased A␤ 42 production in the brains of PS1 mutant transgenic mice (Borchelt et al., 1996; Citron et al., 1997; Duff et al., 1996) . As expected, the A␤ 42 load in these mice was even further increased when the mice coexpressed APP carrying the Swedish
